In my opinion I don't think the filing will be a big event, and IPCI may even sell off some... although I believe the FDA acceptance will be more meaningful.
The share price will take a meaningful upturn with a Rexista partnership, and how big of an upturn is totally dependent on the partnership package.
A couple of other meanigful events will be Patent approval on PODRAS, which will be VERY meanigful but probably will barely move the share price because it's significance will not be appreciated until put into use... and a Regabatin partnership which can be as big, or bigger than Rexista... and can possibly happen even before Rexista partnership.
In my estimation, IPCI will be a $2.5 Billion company in 3 to 5 years and have 50 million shares oustanding by then - making the share price $50 a share.
Find some other means by which you feed yourself till then... perhaps aquire a taste for dog food if necessary... but don't sell till all those milestones are history and IPCI is 80% owned by institutions.
Starting soon... every institution that wants a meanigful share of IPCI will raise the share price by $1.00
20K shares today makes you a millionaire in 3 to 5 years!!!